Tagged with SFDA

Saudi FDA Becomes First Arab Member of PIC/S Pharma Inspection Scheme

Saudi Arabia Saudi FDA Becomes First Arab Member of PIC/S Pharma Inspection Scheme

Saudi Arabia The Saudi Food and Drug Authority (SFDA) has joined the Pharmaceutical Inspection Co-operation Scheme (PIC/S), aimed at harmonising inspection procedures worldwide. Through PIC/S membership the SFDA looks to continue bolstering its capabilities and further its international collaboration efforts. SFDA’s accession to PIC/S is one of the strategic projects of…

Top 2021 Insights from Global Regulators

Global Top 2021 Insights from Global Regulators

Global Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for COVID-19 vaccines have evidently been top of their priority lists, other key topics discussed included the potential of data and AI to change the drug approval…

Saudi Arabia: Significant Steps Towards Clinical Trial Hub Status

Saudi Arabia Saudi Arabia: Significant Steps Towards Clinical Trial Hub Status

Saudi Arabia Clinical trials provide a pathway to innovation for clinicians and patients in countries like Saudi Arabia and form a key element of the country’s Vision 2030 national plan. As Saudi transitions away from oil towards becoming a knowledge-based economy, it is hoping to attract ever more international pharma companies to…

Saudi Arabia: SFDA CEO Sets Out Strategic Priorities

Saudi Arabia Saudi Arabia: SFDA CEO Sets Out Strategic Priorities

Saudi Arabia In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA) outlined the organisation’s strategic priorities. As part of the Authority’s 2018-2022 strategic plan, it has set out a number of goals, ranging from setting clearer objectives to strengthening its capabilities,…

Hisham Bin Saad Al-Jadhey – CEO, Saudi Food and Drug Authority (SFDA)

Saudi Arabia Hisham Bin Saad Al-Jadhey – CEO, Saudi Food and Drug Authority (SFDA)

Saudi Arabia Speaking exclusively to PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA), outlines the SFDA’s key priorities under its current strategic plan. He also touches on why domestic pharma and medtech manufacturing is important to the SFDA, pricing issues for innovative new therapies, and…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page